This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Urinary Incontinence, Multiple Sclerosis or Neurogenic Bladder
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will evaluate the safety and efficacy of OnabotulinumtoxinA (BOTOX®) for the treatment of urinary incontinence due to NDO in non-catheterizing patients with MS.

Provided treatments

  • Biological: OnabotulinumtoxinA
  • Drug: Placebo (Normal Saline)
Tris trial is registered with FDA with number: NCT01600716. The sponsor of the trial is Allergan and it is looking for 144 volunteers for the current phase.
Official trial title: